PortalPublikationenTargeting the phosphoinositide 3-kinase isoform p110delta im...

Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.

Standard

Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. / Boller, Danielle; Schramm, Alexander; Doepfner, Kathrin T; Shalaby, Tarek; von Bueren, André; André, O; Eggert, Angelika; Grotzer, Michael A; Arcaro, Alexandre.

in: CLIN CANCER RES, Jahrgang 14, Nr. 4, 4, 2008, S. 1172-1181.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Boller, D, Schramm, A, Doepfner, KT, Shalaby, T, von Bueren, A, André, O, Eggert, A, Grotzer, MA & Arcaro, A 2008, 'Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.', CLIN CANCER RES, Jg. 14, Nr. 4, 4, S. 1172-1181. <http://www.ncbi.nlm.nih.gov/pubmed/18281552?dopt=Citation>

APA

Boller, D., Schramm, A., Doepfner, K. T., Shalaby, T., von Bueren, A., André, O., Eggert, A., Grotzer, M. A., & Arcaro, A. (2008). Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. CLIN CANCER RES, 14(4), 1172-1181. [4]. http://www.ncbi.nlm.nih.gov/pubmed/18281552?dopt=Citation

Vancouver

Boller D, Schramm A, Doepfner KT, Shalaby T, von Bueren A, André O et al. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. CLIN CANCER RES. 2008;14(4):1172-1181. 4.

Bibtex

@article{3c9bbf374eef4c87a43a5c1de3ffe8e2,
title = "Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.",
abstract = "The phosphoinositide 3-kinase (PI3K)/Akt pathway is frequently activated in human cancer and plays a crucial role in neuroblastoma biology. We were interested in gaining further insight into the potential of targeting PI3K/Akt signaling as a novel antiproliferative approach in neuroblastoma.",
author = "Danielle Boller and Alexander Schramm and Doepfner, {Kathrin T} and Tarek Shalaby and {von Bueren}, Andr{\'e} and O Andr{\'e} and Angelika Eggert and Grotzer, {Michael A} and Alexandre Arcaro",
year = "2008",
language = "Deutsch",
volume = "14",
pages = "1172--1181",
journal = "CLIN CANCER RES",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.

AU - Boller, Danielle

AU - Schramm, Alexander

AU - Doepfner, Kathrin T

AU - Shalaby, Tarek

AU - von Bueren, André

AU - André, O

AU - Eggert, Angelika

AU - Grotzer, Michael A

AU - Arcaro, Alexandre

PY - 2008

Y1 - 2008

N2 - The phosphoinositide 3-kinase (PI3K)/Akt pathway is frequently activated in human cancer and plays a crucial role in neuroblastoma biology. We were interested in gaining further insight into the potential of targeting PI3K/Akt signaling as a novel antiproliferative approach in neuroblastoma.

AB - The phosphoinositide 3-kinase (PI3K)/Akt pathway is frequently activated in human cancer and plays a crucial role in neuroblastoma biology. We were interested in gaining further insight into the potential of targeting PI3K/Akt signaling as a novel antiproliferative approach in neuroblastoma.

M3 - SCORING: Zeitschriftenaufsatz

VL - 14

SP - 1172

EP - 1181

JO - CLIN CANCER RES

JF - CLIN CANCER RES

SN - 1078-0432

IS - 4

M1 - 4

ER -